Attaining optimal asthma control: A practice parameter
These parameters were developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology; the American College of Allergy, Asthma and Immunology; and the Joint Council of Allergy, Asthma and Immunology. The American Academy of Allergy, Asthm...
Gespeichert in:
| Veröffentlicht in: | Journal of allergy and clinical immunology 2005-11, Vol.116 (5), p.S3-S11 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | S11 |
|---|---|
| container_issue | 5 |
| container_start_page | S3 |
| container_title | Journal of allergy and clinical immunology |
| container_volume | 116 |
| creator | Li, James T. Oppenheimer, John Bernstein, I. Leonard Nicklas, Richard A. Khan, David A. Blessing-Moore, Joann Lang, David M. Portnoy, Jay M. Schuller, Diane E. Spector, Sheldon L. Tilles, Stephen A. Wallace, Dana V. |
| description | These parameters were developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology; the American College of Allergy, Asthma and Immunology; and the Joint Council of Allergy, Asthma and Immunology.
The American Academy of Allergy, Asthma and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI) have jointly accepted responsibility for establishing “Attaining optimal asthma control: A practice parameter.” This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or the ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma and Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion. |
| doi_str_mv | 10.1016/j.jaci.2005.08.017 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68878096</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091674905018579</els_id><sourcerecordid>3238965891</sourcerecordid><originalsourceid>FETCH-LOGICAL-c492t-6ef7cbb225bcac363d3ab0fa9181c465ac608b3085c18576b4b0ec2f1092cd103</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMouq7-AQ9SELy1TtI2TcXLsvgFC170HNJpqin9MkkF_71ZdkHw4GkYeN6XmYeQCwoJBcpv2qRVaBIGkCcgEqDFAVlQKIuYC5YfkgVASWNeZOUJOXWuhbCnojwmJ5SnaVYyuiB85b0ygxneo3HyplddpJz_6FWE4-Dt2N1Gq2iyCr1BHU3Kql57bc_IUaM6p8_3c0neHu5f10_x5uXxeb3axBjqfcx1U2BVMZZXqDDlaZ2qChpVUkEx47lCDqJKQeRIRV7wKqtAI2vCEwxrCumSXO96Jzt-ztp52RuHuuvUoMfZSS5EIaDkAbz6A7bjbIdwm6Q5ZEXGeCkCxXYU2tE5qxs52fCz_ZYU5NapbOXWqdw6lSBkcBpCl_vquep1_RvZSwzA3Q7QwcSX0VY6NHpAXRur0ct6NP_1_wC3ioZt</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1504742698</pqid></control><display><type>article</type><title>Attaining optimal asthma control: A practice parameter</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Li, James T. ; Oppenheimer, John ; Bernstein, I. Leonard ; Nicklas, Richard A. ; Khan, David A. ; Blessing-Moore, Joann ; Lang, David M. ; Portnoy, Jay M. ; Schuller, Diane E. ; Spector, Sheldon L. ; Tilles, Stephen A. ; Wallace, Dana V.</creator><creatorcontrib>Li, James T. ; Oppenheimer, John ; Bernstein, I. Leonard ; Nicklas, Richard A. ; Khan, David A. ; Blessing-Moore, Joann ; Lang, David M. ; Portnoy, Jay M. ; Schuller, Diane E. ; Spector, Sheldon L. ; Tilles, Stephen A. ; Wallace, Dana V. ; Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology and Joint Council of Allergy, Asthma and Immunology</creatorcontrib><description>These parameters were developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology; the American College of Allergy, Asthma and Immunology; and the Joint Council of Allergy, Asthma and Immunology.
The American Academy of Allergy, Asthma and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI) have jointly accepted responsibility for establishing “Attaining optimal asthma control: A practice parameter.” This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or the ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma and Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion.</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2005.08.017</identifier><identifier>PMID: 16334921</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Airway management ; Algorithms ; Allergies ; Anti-Asthmatic Agents - therapeutic use ; Asthma ; Asthma - diagnosis ; Asthma - drug therapy ; Bronchodilator Agents - therapeutic use ; Disease management ; Drug dosages ; Humans ; Internal medicine ; Medicine ; Patients ; Prevention programs ; Severity of Illness Index ; Studies ; Task forces</subject><ispartof>Journal of allergy and clinical immunology, 2005-11, Vol.116 (5), p.S3-S11</ispartof><rights>2005</rights><rights>Copyright Elsevier Limited Nov 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c492t-6ef7cbb225bcac363d3ab0fa9181c465ac608b3085c18576b4b0ec2f1092cd103</citedby><cites>FETCH-LOGICAL-c492t-6ef7cbb225bcac363d3ab0fa9181c465ac608b3085c18576b4b0ec2f1092cd103</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jaci.2005.08.017$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16334921$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, James T.</creatorcontrib><creatorcontrib>Oppenheimer, John</creatorcontrib><creatorcontrib>Bernstein, I. Leonard</creatorcontrib><creatorcontrib>Nicklas, Richard A.</creatorcontrib><creatorcontrib>Khan, David A.</creatorcontrib><creatorcontrib>Blessing-Moore, Joann</creatorcontrib><creatorcontrib>Lang, David M.</creatorcontrib><creatorcontrib>Portnoy, Jay M.</creatorcontrib><creatorcontrib>Schuller, Diane E.</creatorcontrib><creatorcontrib>Spector, Sheldon L.</creatorcontrib><creatorcontrib>Tilles, Stephen A.</creatorcontrib><creatorcontrib>Wallace, Dana V.</creatorcontrib><creatorcontrib>Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology and Joint Council of Allergy, Asthma and Immunology</creatorcontrib><title>Attaining optimal asthma control: A practice parameter</title><title>Journal of allergy and clinical immunology</title><addtitle>J Allergy Clin Immunol</addtitle><description>These parameters were developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology; the American College of Allergy, Asthma and Immunology; and the Joint Council of Allergy, Asthma and Immunology.
The American Academy of Allergy, Asthma and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI) have jointly accepted responsibility for establishing “Attaining optimal asthma control: A practice parameter.” This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or the ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma and Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion.</description><subject>Airway management</subject><subject>Algorithms</subject><subject>Allergies</subject><subject>Anti-Asthmatic Agents - therapeutic use</subject><subject>Asthma</subject><subject>Asthma - diagnosis</subject><subject>Asthma - drug therapy</subject><subject>Bronchodilator Agents - therapeutic use</subject><subject>Disease management</subject><subject>Drug dosages</subject><subject>Humans</subject><subject>Internal medicine</subject><subject>Medicine</subject><subject>Patients</subject><subject>Prevention programs</subject><subject>Severity of Illness Index</subject><subject>Studies</subject><subject>Task forces</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LxDAQhoMouq7-AQ9SELy1TtI2TcXLsvgFC170HNJpqin9MkkF_71ZdkHw4GkYeN6XmYeQCwoJBcpv2qRVaBIGkCcgEqDFAVlQKIuYC5YfkgVASWNeZOUJOXWuhbCnojwmJ5SnaVYyuiB85b0ygxneo3HyplddpJz_6FWE4-Dt2N1Gq2iyCr1BHU3Kql57bc_IUaM6p8_3c0neHu5f10_x5uXxeb3axBjqfcx1U2BVMZZXqDDlaZ2qChpVUkEx47lCDqJKQeRIRV7wKqtAI2vCEwxrCumSXO96Jzt-ztp52RuHuuvUoMfZSS5EIaDkAbz6A7bjbIdwm6Q5ZEXGeCkCxXYU2tE5qxs52fCz_ZYU5NapbOXWqdw6lSBkcBpCl_vquep1_RvZSwzA3Q7QwcSX0VY6NHpAXRur0ct6NP_1_wC3ioZt</recordid><startdate>20051101</startdate><enddate>20051101</enddate><creator>Li, James T.</creator><creator>Oppenheimer, John</creator><creator>Bernstein, I. Leonard</creator><creator>Nicklas, Richard A.</creator><creator>Khan, David A.</creator><creator>Blessing-Moore, Joann</creator><creator>Lang, David M.</creator><creator>Portnoy, Jay M.</creator><creator>Schuller, Diane E.</creator><creator>Spector, Sheldon L.</creator><creator>Tilles, Stephen A.</creator><creator>Wallace, Dana V.</creator><general>Mosby, Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SS</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20051101</creationdate><title>Attaining optimal asthma control: A practice parameter</title><author>Li, James T. ; Oppenheimer, John ; Bernstein, I. Leonard ; Nicklas, Richard A. ; Khan, David A. ; Blessing-Moore, Joann ; Lang, David M. ; Portnoy, Jay M. ; Schuller, Diane E. ; Spector, Sheldon L. ; Tilles, Stephen A. ; Wallace, Dana V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c492t-6ef7cbb225bcac363d3ab0fa9181c465ac608b3085c18576b4b0ec2f1092cd103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Airway management</topic><topic>Algorithms</topic><topic>Allergies</topic><topic>Anti-Asthmatic Agents - therapeutic use</topic><topic>Asthma</topic><topic>Asthma - diagnosis</topic><topic>Asthma - drug therapy</topic><topic>Bronchodilator Agents - therapeutic use</topic><topic>Disease management</topic><topic>Drug dosages</topic><topic>Humans</topic><topic>Internal medicine</topic><topic>Medicine</topic><topic>Patients</topic><topic>Prevention programs</topic><topic>Severity of Illness Index</topic><topic>Studies</topic><topic>Task forces</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, James T.</creatorcontrib><creatorcontrib>Oppenheimer, John</creatorcontrib><creatorcontrib>Bernstein, I. Leonard</creatorcontrib><creatorcontrib>Nicklas, Richard A.</creatorcontrib><creatorcontrib>Khan, David A.</creatorcontrib><creatorcontrib>Blessing-Moore, Joann</creatorcontrib><creatorcontrib>Lang, David M.</creatorcontrib><creatorcontrib>Portnoy, Jay M.</creatorcontrib><creatorcontrib>Schuller, Diane E.</creatorcontrib><creatorcontrib>Spector, Sheldon L.</creatorcontrib><creatorcontrib>Tilles, Stephen A.</creatorcontrib><creatorcontrib>Wallace, Dana V.</creatorcontrib><creatorcontrib>Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology and Joint Council of Allergy, Asthma and Immunology</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, James T.</au><au>Oppenheimer, John</au><au>Bernstein, I. Leonard</au><au>Nicklas, Richard A.</au><au>Khan, David A.</au><au>Blessing-Moore, Joann</au><au>Lang, David M.</au><au>Portnoy, Jay M.</au><au>Schuller, Diane E.</au><au>Spector, Sheldon L.</au><au>Tilles, Stephen A.</au><au>Wallace, Dana V.</au><aucorp>Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology and Joint Council of Allergy, Asthma and Immunology</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Attaining optimal asthma control: A practice parameter</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><addtitle>J Allergy Clin Immunol</addtitle><date>2005-11-01</date><risdate>2005</risdate><volume>116</volume><issue>5</issue><spage>S3</spage><epage>S11</epage><pages>S3-S11</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>These parameters were developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology; the American College of Allergy, Asthma and Immunology; and the Joint Council of Allergy, Asthma and Immunology.
The American Academy of Allergy, Asthma and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI) have jointly accepted responsibility for establishing “Attaining optimal asthma control: A practice parameter.” This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or the ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma and Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion.</abstract><cop>United States</cop><pub>Mosby, Inc</pub><pmid>16334921</pmid><doi>10.1016/j.jaci.2005.08.017</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0091-6749 |
| ispartof | Journal of allergy and clinical immunology, 2005-11, Vol.116 (5), p.S3-S11 |
| issn | 0091-6749 1097-6825 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68878096 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present); EZB-FREE-00999 freely available EZB journals |
| subjects | Airway management Algorithms Allergies Anti-Asthmatic Agents - therapeutic use Asthma Asthma - diagnosis Asthma - drug therapy Bronchodilator Agents - therapeutic use Disease management Drug dosages Humans Internal medicine Medicine Patients Prevention programs Severity of Illness Index Studies Task forces |
| title | Attaining optimal asthma control: A practice parameter |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T08%3A51%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Attaining%20optimal%20asthma%20control:%20A%20practice%20parameter&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Li,%20James%20T.&rft.aucorp=Joint%20Task%20Force%20on%20Practice%20Parameters,%20American%20Academy%20of%20Allergy,%20Asthma%20and%20Immunology;%20American%20College%20of%20Allergy,%20Asthma%20and%20Immunology%20and%20Joint%20Council%20of%20Allergy,%20Asthma%20and%20Immunology&rft.date=2005-11-01&rft.volume=116&rft.issue=5&rft.spage=S3&rft.epage=S11&rft.pages=S3-S11&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2005.08.017&rft_dat=%3Cproquest_cross%3E3238965891%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1504742698&rft_id=info:pmid/16334921&rft_els_id=S0091674905018579&rfr_iscdi=true |